To assess the reason as to why IL-33 modulates cell cycle progression in primary ALL cells, the expression of CDK1, and cyclin B1 in the treated ALL cells (as elucidated above) was examined. This evidence concerns the gene IL33 and acute lymphoblastic leukemia.